Nivalis Therapeutics (NVLS) – Management Comments
-
Nivalis Therapeutics (NVLS) Says Cavosonstat Phase 2 Clinical Trial in CF Missed Primary Endpoint
-
Nivalis Therapeutics (NVLS) Approves Corporate Restructuring; CEO to Step Down
-
-
-
-
-
-
-
-
Back to NVLS Stock Lookup